Journal of Antimicrobial Chemotherapy · 2017 · 54 citations · 13 references
PharmacyHealth PolicyAntimicrobial StewardshipClinical Decision SupportImplementation ScienceAntibiotic Prescribing PrinciplesClinical Decision Support For PrescribingGuideline ImplementationHospital Antimicrobial StewardshipImplementation AssessmentAntimicrobial Policy ImplementationAntimicrobial Prescribing PatternsEmpirical Therapy CoverageImplementation Of Antimicrobial PoliciesInpatient Antimicrobial StewardshipInterrupted Series AnalysisStewardship ImplementationStewardship Intervention Implementation
Objectives: To evaluate the impact of adding a mobile health (mHealth) decision support system for antibiotic prescribing to an established antimicrobial stewardship programme (ASP). Methods: In August 2011, the antimicrobial prescribing policy was converted into a mobile application (app). A segmented regression analysis of interrupted time series was used to assess the impact of the app on prescribing indicators, using data (2008-14) from a biannual point prevalence survey of medical and surgical wards. There were six data points pre-implementation and six data points post-implementation. Results: There was an increase in compliance with policy (e.g. compliance with empirical therapy or expert advice) in the two specialties of medicine (6.48%, 95% CI = -1.25 to 14.20) and surgery (6.63%, 95% CI = 0.15-13.10) in the implementation period, with a significant sudden change in level in surgery ( P < 0.05). There was an increase, though not significant, in medicine (15.20%, 95% CI = -17.81 to 48.22) and surgery (35.97%, 95% CI = -3.72 to 75.66) in the percentage of prescriptions that had a stop/review date documented. The documentation of indication decreased in both medicine (-16.25%, 95% CI = -42.52 to 10.01) and surgery (-14.62%, 95% CI = -42.88 to 13.63). Conclusions: Introducing the app into an existing ASP had a significant impact on the compliance with policy in surgery, and a positive, but not significant, effect on documentation of stop/review date in both specialties. The negative effect on the third indicator may reflect a high level of compliance pre-intervention, due to existing ASP efforts. The broader value of providing an antimicrobial policy on a digital platform, e.g. the reach and access to the policy, should be measured using indicators more sensitive to mHealth interventions.
13
Craig Ramsay, Lloyd Matowe, Roberto Grilli et al. · International Journal of Technology Assessment in Health Care · 2003 · 717 citations
Public Health, Health Behavior, Health Services Research +14
Diane Ashiru‐Oredope, Mike Sharland, Esmita Charani et al. · Journal of Antimicrobial Chemotherapy · 2012 · 253 citations · Full text